Inventor · disambiguated record
Jörg Von Wegerer
Also filed as: VON WEGERER JÖRG
7 granted patents·12 pending applications·5 citations·filing 2015–2024
73Inventor score
Top patents by PatentIndex Score
19 records- 0182US11497760B2Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agentsATHENION AG·Filed 2017·Granted Nov 15, 2022·2 cites·7 claims
- 0275US11007192B2Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosisMETRIOPHARM AG·Filed 2017·Granted May 18, 2021·2 cites·11 claims
- 0370US2025051288A1Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedioneMETRIOPHARM AG·Filed 2024·Application pending·0 cites
- 0463US10258620B2Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said formMETRIOPHARM AG·Filed 2015·Granted Apr 16, 2019·1 cites·2 claims
- 0559US2025064801A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of congenital muscular dystrophiesMETROPHARM AG·Filed 2023·Application pending·0 cites
- 0659US2025064800A1Combination of budesonide and 5-amino-2,3-dihydro-1,4-phthalazinedioneMETROPHARM AG·Filed 2023·Application pending·0 cites
- 0758US12122753B2Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedioneMETRIOPHARM AG·Filed 2019·Granted Oct 22, 2024·0 cites·8 claims
- 0855US2025032486A1Combination of 5-amino-2,3-dihydro-1,4-phtalazinedione and a 6'-methoxycinchonan-9-ol for use in the treatment of coronaviral infectionsMETROPHARM AG·Filed 2022·Application pending·0 cites
- 0952US11111218B2Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dioneMETRIOPHARM AG·Filed 2017·Granted Sep 7, 2021·0 cites·9 claims
- 1051US2023241060A1Glucocorticoid-sparing agentMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 1149US2023218614A1Compound for the treatment of coronaviral infectionsMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 1248US2023113516A15-amino-2,3-dihydro-1,4-phthalazinedione for treatment of acute lung injuryMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 1347US2023053455A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseasesMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 1446US2023061223A1Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the inhalatory treatment of inflammatory pulmonary diseasesMETRIOPHARM AG·Filed 2021·Application pending·0 cites
- 1545US2023103704A1Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary issuesADVITA LIFESCIENCE GMBH·Filed 2021·Application pending·0 cites
- 1642US11203575B2Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dioneMETRIOPHARM AG·Filed 2017·Granted Dec 21, 2021·0 cites·4 claims
- 1739US2020113824A1Dispensing cap containing a solubilisate of a pharmaceutically active agent or dietary supplementATHENION AG·Filed 2018·Application pending·0 cites
- 1835US2019084757A1Beverage preparation capsule for delivery of a solubilisateBRYSCH EKKEHARD·Filed 2017·Application pending·0 cites
- 1931US10588896B2Agents for the treatment of retroviral infectious diseasesIMMUNOLOGIK GMBH·Filed 2015·Granted Mar 17, 2020·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Jörg Von Wegerer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →